Pharmaceutical Aspects of the Recombinant Human Serum Albumin Dimer: Structural Characteristics, Biological Properties, and Medical Applications
- 1 September 2012
- journal article
- review article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 101 (9) , 3033-3046
Abstract
No abstract availableKeywords
This publication has 95 references indexed in Scilit:
- Impact of albumin on drug delivery — New applications on the horizonJournal of Controlled Release, 2012
- Use of the molecular adsorbent recirculating system (MARS™) for the management of acute poisoning with or without liver failureClinical Toxicology, 2011
- Albinterferon Alfa-2b Was Not Inferior to Pegylated Interferon-α in a Randomized Trial of Patients With Chronic Hepatitis C Virus Genotype 2 or 3Gastroenterology, 2010
- Size and Dynamics of Caveolae Studied Using Nanoparticles in Living Endothelial CellsACS Nano, 2009
- A Review of Blood Substitutes: Examining The History, Clinical Trial Results, and Ethics of Hemoglobin-Based Oxygen CarriersClinics, 2009
- S-Nitrosylated Human Serum Albumin-mediated Cytoprotective Activity Is Enhanced by Fatty Acid BindingJournal of Biological Chemistry, 2008
- Volume resuscitation from hemorrhagic shock with albumin and hexaPEGylated human serum albuminResuscitation, 2008
- Solid tumor physiology and hypoxia-induced chemo/radio-resistance: Novel strategy for cancer therapy: Nitric oxide donor as a therapeutic enhancerNitric Oxide, 2008
- Survival time in severe hemorrhagic shock after perioperative hemodilution is longer with PEG-conjugated human serum albumin than with HES 130/0.4: a microvascular perspectiveCritical Care, 2008
- Dimerization of Serum Mercaptalbumin in Presence of Mercurials. II. Studies with a Bifunctional Organic Mercurial1a,b,cJournal of the American Chemical Society, 1954